[{"id":"1060c7ca-0db7-45ed-babc-f64f37892f87","acronym":"","url":"https://clinicaltrials.gov/study/NCT00905060","created_at":"2021-03-24T18:52:25.085Z","updated_at":"2024-07-02T16:36:32.909Z","phase":"Phase 2","brief_title":"HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM","source_id_and_acronym":"NCT00905060","lead_sponsor":"University of California, San Francisco","biomarkers":" PD-L1 • PTPRC • ITGAM","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1 • PTPRC • ITGAM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • Oncophage (Heat Shock Protein Peptide Complex-96)"],"overall_status":"Completed","enrollment":" Enrollment 70","initiation":"Initiation: 06/29/2009","start_date":" 06/29/2009","primary_txt":" Primary completion: 06/03/2014","primary_completion_date":" 06/03/2014","study_txt":" Completion: 06/03/2014","study_completion_date":" 06/03/2014","last_update_posted":"2021-03-24"}]